Market Research Logo

Veterinary Vaccines (Canine Vaccines, Feline Vaccines, Livestock Vaccines, etc.)

Veterinary Vaccines (Canine Vaccines, Feline Vaccines, Livestock Vaccines, etc.)

This report analyzes the worldwide markets for Veterinary Vaccines in US$ by the following Product Segments: Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 102 companies including many key and niche players such as -

Bayer AG
Biogenesis Bago SA
Boehringer Ingelheim International GmbH
Ceva Santé Animale
Elanco Animal Health
Diamond Animal Health

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


1. INTRODUCTION, METHODOLOGY & PRODUCT PRODUCT PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
A. Companion Animal Vaccines
B. Livestock Vaccines
Porcine Vaccines
Bovine Vaccines
Poultry Vaccines
Ovine Vaccines
Equine Vaccines
Other Animal Vaccines
2. INDUSTRY OVERVIEW
Market Outlook
Important Animal Diseases
Veterinary Vaccines Market on a Growth Trajectory
Livestock Vaccines Rule the Roost
Select Animal Disease Vaccines
Mature Markets Vis-a-vis Emerging Markets
Veterinary Vaccines Market based on Technology
-Live Attenuated Vaccines
-Killed/Inactivated Vaccines
-Recombinant vector vaccines
Table 1: Worldwide Veterinary Vaccines byTechnology (2017): Market Share Breakdown(In %) for Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vector Vaccines,Toxoid Vaccines, and DNA Vaccines(includes corresponding Graph/Chart)
Recombinant DNA Technology to TakeOver the Industry
Vector-based Vaccines
DNA Vaccines
Subunit and Virus-Like Particle (VLP)-based vaccines
Targeted Deletions/Modifications-based Vaccines
Collaborative R&D for Various Types of Veterinary Vaccines
Market Challenges
3. GROWTH DRIVERS AND MARKET TRENDS
Need to Ensure Sustainable Food SupplySpurs Growth
Table 2: Top Countries Worldwide in Terms ofPopulation (July 2018) (in Million) (includescorresponding Graph/Chart)
Table 3: Worldwide Protein Consumption (kt): 2016-2020 (includes corresponding Graph/Chart)
Increasing Demand for Animal Proteinin Developing Countries to Benefit the Market
Table 4: Per Capita Meat Consumption for Select Countries (In LB/per capita): 2017 (includes corresponding Graph/Chart)
Increasing Pet Ownership Drives Demandfor Companion Animal Vaccines
Table 5: Global Pet Dog Population (2017): Numberof Pet Dogs by Select Countries (in Millions)(includes corresponding Graph/Chart)
Table 6: Global Pet Cat Population (2017): Numberof Pet Cats by Select Countries (in Millions)(includes corresponding Graph/Chart)
Table 7: Global Pet Birds Population (2017): Number of Pet Birds by Select Countries (in Millions)(includes corresponding Graph/Chart)
Table 8: Global Pet Fish Population (2017): Number of Pet Fish by Select Countries (in Millions)(includes corresponding Graph/Chart)
Spread of Zoonotic Diseases Propels Growth ofVeterinary Vaccines
Social Concerns on Slaughtering Presentsa Valid Case for Use of Vaccines
Novel Trends in Animal Vaccine Development
Reduced Response Time
Drug Resistance
Serotype Cross-Protection
Innovative Manufacturing
Technological Advancements
Porcine Market Offers Significant Prospectsfor Growth and New Vaccine Development
Select Swine Diseases
Select Key Marketed Porcine Reproductive andRespiratory Syndrome (PRRS) Vaccines
Porcine Epidemic Diarrhea Virus (PEDV) VaccinesAvailable in Select Countries
Improvised Adjuvant Usage and VeterinaryVaccine Delivery Systems
Anthrax and Other Vaccines with Improved Adjuvants in the Pipeline
Matrix™ Adjuvant Technology by Novavax
Global Efforts to Conquer FMD by an Effective Vaccine
Member Countries with Endorsed Official ControlProgramme for FMD
FMD Free Zone Where Vaccination Is Practised
Foot-and-Mouth Disease Vaccines Available
Developments in the Poultry Vaccine Market
Vaccination – Critical for Controlling Avian Influenza Virus
Avian Influenza Vaccines
New Effervescent Tablets Vaccines against NDV –Augmenting Trend towards Convenient Administration
Vaccination in the Hatchery Gains Momentum
Parasitic Vaccines Segment Holds Potential
Egg-Derived Veterinary Vaccines in HumanVaccine Facilities
New Vaccine Strains – The Imminent Needin the Vaccine Market
The Need for Innovative Vaccine DeliveryMechanism Increasing
More Vaccines Needed to Prevent Zoonotic Infections
Plant-based Vaccines – the Next Avenue in Cost- effective and Efficacious Vaccines; Obstacles Persist Delaying Market Debut
Pricing Affects the Livestock Vaccine Market
Over-Vaccination Trend May Prove Harmful
4. PRODUCT OVERVIEW
Vaccines – An Evolutionary Scan
Veterinary Medicines – A Brief Review
Concept Development
Production of Vaccines
Veterinary Vaccines – An Essential Component of Animal Healthcare
What Does A Veterinary Vaccine Do?
Classification of Veterinary Vaccines
Companion Animal Vaccines
Canine Vaccines
Canine Distemper
Canine Parvovirus
Tracheobronchitis
Canine Coronavirus
Canine Leptospirosis
Canine Giardia
Canine Lyme borreliosis
Canine Rabies
Feline Vaccines
Feline Panleukopenia Virus Vaccine
Feline Calicivirus & Herpesvirus Vaccine
Rabies Virus Vaccine
Feline Leukemia Virus Vaccine
Chlamydia, Feline Infectious Peritonitis, and Ringworm Vaccines
Livestock Vaccines
Bovine Vaccines
Bovine virus diarrhoea – Mucosal disease (BVD-MD)
Johne's disease
Infectious Bovine Rhinotracheitis (IBR)
Blackleg
Neosporosis
Poultry Vaccines
Ovine Vaccines
Porcine Vaccines
Equine Vaccines
Aquaculture Vaccines
A Tabular Analysis on Select Animal DiseasesControlled by Vaccines
Vaccination and Its Reactions
Veterinary Vaccines – Latest Breakthroughs
Marker/DIVA Vaccines
DNA Vaccines
Gene-Deleted Vaccines
Viral-Vectored Vaccines
5. NOTES ON SELECT ANIMAL DISEASES
Brucellosis
Tuberculosis
Johne’s disease
Spirochete Associated Diseases
Respiratory Disease in Goats, Sheep, and Cattle
Porcine Respiratory Diseases
Mastitis
African Swine Fever
Avian Influenza
East Coast Fever
Hemorrhagic Septicemia
Foot-And-Mouth Disease
Japanese Encephalitis
Rift Valley Fever
Equine Virus Infection
6. COMPETITIVE LANDSCAPE
6.1 Focus on Select Key Players
Bayer AG (Germany)
Biogenesis Bago SA (Argentina)
Boehringer Ingelheim International GmbH (Germany)
Ceva Santé Animale (France)
Elanco Animal Health (USA)
Diamond Animal Health (USA)
Indian Immunologicals Ltd. (India)
Merck Animal Health (USA)
Virbac SA (France)
Zoetis Inc. (USA)
6.2 Product Launches and Innovations
Elanco Animal Health Launches Novel RespiratoryPRRS Vaccine
Merck Animal Health Launches SEQUIVITY™Technology
Merck Animal Health Launches Updated EquineInfluenza Vaccines
Hipra Introduces Smart Vaccination
Ceva Introduces New Technology Vaccines
Merial, Boehringer Introduces Needle-free CanineVaccine
Zoetis Introduces Vanguard® CIV H3N2/H3N8 Vaccine
HIPRA Canada Animal Health IntroducesERYSENG® PARVO
MSD Animal Health Introduces First Live PoultryVaccine
Aptimmune Introduces World's First MucosalPRRSV Vaccine
AgriLabs Plans to Commercialize DNA VaccinePlatform
HIPRA Introduces STARTVAC® in Korea
MSD Animal Health Unveils PORCILIS PCV ID
Virbac Rolls Out Lepto4 Vaccine
6.3 Recent Industry Activity
PHARMAQ Signs Agreement with Vinh Hoanfor Pangasius Vaccine
Boehringer Ingelheim Announces Plans for Establishing Strategic Production Center for Veterinary Public Health in France
MSD Animal Health Announces Partnership withVinovo to Enhance Poultry Health
Wageningen Bioveterinary Research Collaborates with Ceva Santé Animale to Develop Veterinary Vaccines
Zoetis Plans to Expand Animal Vaccine Researchand Manufacturing in Suzhou, China
Boehringer Ingelheim Invests €65 Million in Avian Vaccines
Three Animal Health Companies Announces Joint Venture to Launch Vaccine for FMD in China
Huvepharma Acquires AgriLabs
Merck Animal Health Acquires Prondil S.A.
MSD Animal Health Agrees with Laboratórios LETI to Distribute LetiFend® Vaccine
MSD Animal Health Plans to PurchaseNew Manufacturing Facility in Krems, Austria
Ceva Phylaxia Completes the Inauguration ofNew European Vaccine Plant
Elanco Inaugurates Autogenous Poultry Vaccine Manufacturing Facility in Winslow, Maine
EU Authorizes First DNA Vaccine to Protect AgainstSalmon Pancreas Disease in Atlantic Salmon
Agrilabs Receives USDA Approval of the FirstDNA Vaccine for Chickens
Elanco Animal Health Acquires Boehringer Ingelheim Vetmedica's U.S. Feline, Canine and Rabies Vaccines Portfolio
Ceva Santé Animale Agrees with EBVAC to Forma New Business Venture, Ceva EBVAC
Ceva Completes the Acquisition of Merial’s Diversified Product Portfolio from Boehringer Ingelheim
IDT Biologika Acquires Ridgeway Biologicals Ltd
Boehringer Ingelheim Acquires Merial
PHARMAQ Acquires Nordland Sett Vak
Plumbline Life Sciences Receives License forInovio's Foot and Mouth Disease DNA Vaccine
Bayer Teams Up with BioNTech for Development of Innovative Veterinary mRNA Vaccines
Harrisvaccines Secures Production PlatformVaccine Licensure from USDA
Orix to Acquire Kyoto Biken
Phibro to Take Over Vaccine Assets of MVPLaboratories
7. GLOBAL MARKET PERSPECTIVE
Table 9: World Recent Past, Current & Future Analysisfor Veterinary Vaccines by Geographic Region - US,Europe and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includescorresponding Graph/Chart)
Table 10: World Historic Review for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 11: World 14-Year Perspective for Veterinary Vaccines by Geographic Region - PercentageBreakdown of Dollar Sales for US, Europe andRest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
Table 12: World Recent Past, Current & FutureAnalysis for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024(includes corresponding Graph/Chart)
Table 13: World Historic Review for Companion Animal Vaccines by Geographic Region - US, Europe andRest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2011through 2015 (includes corresponding Graph/Chart)
Table 14: World 14-Year Perspective for CompanionAnimal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe andRest of World Markets for Years 2011, 2018 and2024 (includes corresponding Graph/Chart)
Table 15: World Recent Past, Current & FutureAnalysis for Companion Animal Vaccines by Product Segment - Canine Vaccines and Feline VaccinesMarkets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 16: World Historic Review for Companion Animal Vaccines by Product Segment - Canine Vaccines and Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011through 2015 (includes corresponding Graph/Chart)
Table 17: World 14-Year Perspective for CompanionAnimal Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Canine Vaccines andFeline Vaccines Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
Table 18: World Recent Past, Current & Future Analysisfor Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016through 2024 (includes corresponding Graph/Chart)
Table 19: World Historic Review for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 20: World 14-Year Perspective for CanineVaccines by Geographic Region - PercentageBreakdown of Dollar Sales for US, Europe andRest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
Table 21: World Recent Past, Current & Future Analysisfor Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016through 2024 (includes corresponding Graph/Chart)
Table 22: World Historic Review for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 23: World 14-Year Perspective for Feline Vaccines by Geographic Region - Percentage Breakdown ofDollar Sales for US, Europe and Rest of WorldMarkets for Years 2011, 2018 and 2024(includes corresponding Graph/Chart)
Table 24: World Recent Past, Current & Future Analysisfor Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Millionfor Years 2016 through 2024 (includescorresponding Graph/Chart)
Table 25: World Historic Review for Livestock Vaccinesby Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 26: World 14-Year Perspective for LivestockVaccines by Geographic Region - Percentage Breakdownof Dollar Sales for US, Europe and Rest of WorldMarkets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
Table 27: World Recent Past, Current & Future Analysisfor Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2016 through2024 (includes corresponding Graph/Chart)
Table 28: World Historic Review for Livestock Vaccinesby Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 29: World 14-Year Perspective for LivestockVaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets for Years2011, 2018 and 2024 (includes correspondingGraph/Chart)
Table 30: World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016through 2024 (includes corresponding Graph/Chart)
Table 31: World Historic Review for Porcine Vaccinesby Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 32: World 14-Year Perspective for PorcineVaccines by Geographic Region - PercentageBreakdown of Dollar Sales for US, Europe andRest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
Table 33: World Recent Past, Current & Future Analysisfor Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016through 2024 (includes corresponding Graph/Chart)
Table 34: World Historic Review for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through2015 (includes corresponding Graph/Chart)
Table 35: World 14-Year Perspective for BovineVaccines by Geographic Region - PercentageBreakdown of Dollar Sales for US, Europe andRest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
Table 36: World Recent Past, Current & FutureAnalysis for Poultry Vaccines by GeographicRegion - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2016 through 2024(includes corresponding Graph/Chart)
Table 37: World Historic Review for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 38: World 14-Year Perspective for PoultryVaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of WorldMarkets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
Table 39: World Recent Past, Current & Future Analysisfor Ovine Vaccines by Geographic Region - US, Europeand Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016through 2024 (includes corresponding Graph/Chart)
Table 40: World Historic Review for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 41: World 14-Year Perspective for OvineVaccines by Geographic Region - PercentageBreakdown of Dollar Sales for US, Europe andRest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
Table 42: World Recent Past, Current & Future Analysis for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 43: World Historic Review for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 44: World 14-Year Perspective for EquineVaccines by Geographic Region - PercentageBreakdown of Dollar Sales for US, Europe andRest of World Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
Table 45: World Recent Past, Current & Future Analysisfor Other Animal Vaccines by Geographic Region -US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millionfor Years 2016 through 2024 (includescorresponding Graph/Chart)
Table 46: World Historic Review for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 47: World 14-Year Perspective for OtherAnimal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe andRest of World Markets for Years 2011, 2018 and2024 (includes corresponding Graph/Chart)
8. REGIONAL MARKET PERSPECTIVE
8.1 The United States
A. Market Analysis
Food Safety Concerns and BiotechnologicalOfferings Drive the Veterinary Vaccines Market
List of Select Veternary Vaccines Available in the US
H5N1 Virus: A Conundrum for the US Industry
Increasing Pet Ownership – An Insight
Table 48: Pet Ownership in the US byHousehold Penetration Rate (1998- 2017)(includes corresponding Graph/Chart)
Table 49: Pet Ownership in the US byGeneration (in %): 2017 (includes corresponding Graph/Chart)
Table 50: Pet Ownership in the US (2017):Number of Households that Own a Pet byAnimal Type (in Millions) (includes corresponding Graph/Chart)
Table 51: US Pet Population (2017): Breakdownof Number of Pets by Category (in Millions)(includes corresponding Graph/Chart)
B. Market Analytics
Table 52: The US Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines(Canine Vaccines and Feline Vaccines) andLivestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 53: The US Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (PorcineVaccines, Bovine Vaccines, Poultry Vaccines,Ovine Vaccines, Equine Vaccines and Others)Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 54: The US 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines)and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,Equine Vaccines and Others) Marketsfor Years 2011, 2018 and 2024 (includescorresponding Graph/Chart)
8.2 Europe
A. Market Analysis
Steady Market Growth Expected Due to Superior Livestock Management
List of Available Veterinary Vaccines in Europe
Regulations
EU Animal Welfare Strategy
B. Market Analytics
Table 55: European Recent Past, Current & Future Analysis for Veterinary Vaccines by GeographicRegion - France, Germany, Italy, UK, Spain, andRest of Europe Markets Independently Analyzedwith Annual Sales Figures in US$ Thousandfor Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 56: European Historic Review for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 57: European 14-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Marketsfor Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
Table 58: European Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines(Canine Vaccines and Feline Vaccines) andLivestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,Equine Vaccines and Others) MarketsIndependently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 59: European Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 60: European 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines)and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Marketsfor Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
8.2.1 France
A. Market Analysis
Current & Future Analysis
B. Market Analytics
Table 61: French Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines(Canine Vaccines and Feline Vaccines) andLivestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,Equine Vaccines and Others) MarketsIndependently Analyzed with Annual SalesFigures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 62: French Historic Review for Veterinary Vaccines by Product Group/Segment -Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines,Ovine Vaccines, Equine Vaccines and Others)Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 63: French 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets for Years 2011,2018 and 2024 (includes corresponding Graph/Chart)
8.2.2 Germany
A. Market Analysis
Current & Future Analysis
Pet Population in Germany
Table 64: Pet Population in Germany by Type:2017 (in Million) (includes correspondingGraph/Chart)
B. Market Analytics
Table 65: German Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines(Canine Vaccines and Feline Vaccines) andLivestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,Equine Vaccines and Others) MarketsIndependently Analyzed with Annual SalesFigures in US$ Thousand for Years 2016 through2024 (includes corresponding Graph/Chart)
Table 66: German Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (PorcineVaccines, Bovine Vaccines, Poultry Vaccines,Ovine Vaccines, Equine Vaccines and Others)Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 67: German 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines)and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
8.2.3 Italy
Market Analysis
Table 68: Italian Recent Past, Current & FutureAnalysis for Veterinary Vaccines by Product Group/ Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 69: Italian Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (PorcineVaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 70: Italian 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines)and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,Equine Vaccines and Others) Marketsfor Years 2011, 2018 and 2024 (includescorresponding Graph/Chart)
8.2.4 The United Kingdom
A. Market Analysis
Current & Future Analysis
Pet Population in the UK
Table 71: Pet Population in the UK by Type (2017) (In Million) (includes corresponding Graph/Chart)
Table 72: Percentage of Households with Pet in the UK by Pet Type (2017) (includescorresponding Graph/Chart)
B. Market Analytics
Table 73: The UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/ Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 74: The UK Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (PorcineVaccines, Bovine Vaccines, Poultry Vaccines,Ovine Vaccines, Equine Vaccines and Others)Markets Independently Analyzed with AnnualSales Figures in US$ Thousand for Years 2011through 2015 (includes correspondingGraph/Chart)
Table 75: The UK 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines)and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,Equine Vaccines and Others) Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
8.2.5 Spain
Market Analysis
Table 76: Spanish Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/ Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 77: Spanish Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (PorcineVaccines, Bovine Vaccines, Poultry Vaccines,Ovine Vaccines, Equine Vaccines and Others)Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 78: Spanish 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines)and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
8.2.6 Rest of Europe
A. Market Analysis
Current & Future Analysis
A Review of Select Regional Markets
The Netherlands
Denmark
Russia Mass-Produces Vaccines against Avian Flu
B. Market Analytics
Table 79: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets Independently Analyzed with Annual Sales Figuresin US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 80: Rest of Europe Historic Review forVeterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccinesand Feline Vaccines) and Livestock Vaccines(Porcine Vaccines, Bovine Vaccines, PoultryVaccines, Ovine Vaccines, Equine Vaccinesand Others) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 81: Rest of Europe 14-Year Perspectivefor Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (PorcineVaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) Markets for Years 2011, 2018 and 2024(includes corresponding Graph/Chart)
8.3 Rest of World
A. Market Analysis
Current & Future Analysis
Focus on Select Markets
ASIA-PACIFIC
Table 82: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024(includes corresponding Graph/Chart)
Table 83: Asia-Pacific Historic Review forVeterinary Vaccines by Region - China andRest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015(includes corresponding Graph/Chart)
Table 84: Asia-Pacific 14-Year Perspective for Veterinary Vaccines by Region - Percentage Breakdown of Dollar Sales for China and Rest of Asia-Pacific Markets for Years 2011, 2018 and2024 (includes corresponding Graph/Chart)
CHINA
Increased Livestock Output and Emerging Pet Industry Lead to Higher VaccineDemand
Table 85: Chinese Recent Past, Current & Future Analysis for Veterinary Vaccinesby Product Segment - Porcine Vaccines,Poultry Vaccines, and Others Markets Independently Analyzed with AnnualSales Figures in US$ Thousandfor Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 86: Chinese Historic Review for Veterinary Vaccines by Product Segment - Porcine Vaccines, Poultry Vaccines, andOthers Markets Independently Analyzedwith Annual Sales Figures in US$ Thousandfor Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 87: Chinese 14-Year Perspective for Veterinary Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Poultry Vaccines, and Others Markets for Years 2011, 2018 and 2024 (includes corresponding Graph/Chart)
Growing Pet Industry Holds Promise
Threat of Avian Influenza Outbreaks CreatesMarket for Effective Vaccine
Demand for Higher-Quality Swine Fever Vaccine
Demand for Effective PRRS Vaccines by Foreign Manufacturers
FMD Epidemics Cause Increased demand for Vaccine
Effective Rabies Vaccine Needed to Curb Dog Menace
Highly Consolidated Chinese Veterinary Market
REST OF ASIA-PACIFIC
India
Animal Vaccines Market to Surge
Table 88: Indian Animal Health Products Market by Segment (2017): Percentage Breakdown of Value Sales for Feed Supplements, Therapeutics and Vaccines (includes corresponding Graph/Chart)
Major Players
New Opportunities Exist despite Well Established Market
Table 89: Indian Veterinary VaccinesMarket by Segment (2017): Percentage Breakdown of Value Sales for Companion Animals, Livestock and Poultry (includes corresponding Graph/Chart)
NORTH KOREA
TAIWAN
Taiwan’s Animal Healthcare Industryunder Scan
AUSTRALIA
A Note on Australian VeterinaryTherapeutics Market
Sizing the Market
Table 90: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines Market Analyzed in US$ Thousandfor Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 91: Rest of Asia-Pacific HistoricReview for Veterinary Vaccines Market Analyzed in US$ Thousand for Years 2011 through 2015 (includescorresponding Graph/Chart)
LATIN AMERICA
Current & Future Analysis
Table 92: Latin American Recent Past,Current & Future Analysis for VeterinaryVaccines by Region - Brazil and Rest ofLatin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousandfor Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 93: Latin American Historic Review for Veterinary Vaccines by Region - Brazil andRest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015(includes corresponding Graph/Chart)
Table 94: Latin American 14-Year Perspectivefor Veterinary Vaccines by Region - Percentage Breakdown of Dollar Sales for Brazil andRest of Latin America Markets for Years2011, 2018 and 2024 (includescorresponding Graph/Chart)
CANADA
Overview of the Canadian Animal HealthIndustry
Imports and Manufacture of Veterinary Biologics
First to Access E. coli 0157:H7 Vaccine
B. Market Analytics
Table 95: Rest of World Recent Past, Current &Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Others) MarketsIndependently Analyzed with Annual Sales Figuresin US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 96: Rest of World Historic Review forVeterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines,Ovine Vaccines, Equine Vaccines and Others)Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 97: Rest of World 14-Year Perspectivefor Veterinary Vaccines by Product Group/ Segment - Percentage Breakdown of DollarSales for Companion Animal Vaccines(Canine Vaccines and Feline Vaccines)and Livestock Vaccines (PorcineVaccines, Bovine Vaccines, PoultryVaccines, Ovine Vaccines, EquineVaccines and Others) Marketsfor Years 2011, 2018 and 2024(includes corresponding Graph/Chart)
9. COMPANY PROFILES Total Companies Profiled: 94 (including Divisions/Subsidiaries - 110)
The United States (21)
Canada (1)
Japan (6)
Europe (28)
- France (5)
- Germany (5)
- The United Kingdom (5)
- Italy (2)
- Spain (4)
- Rest of Europe (7)
Asia-Pacific (Excluding Japan) (31)
Middle East (4) Latin America (14)
Africa (5)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report